Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Vistagen Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 58
- +7 vs. Q2 2025
- Shares held
- 23.4M
- +7.87M (+50.8%) vs. Q2 2025
- Total value
- $81.8M
- +$51.5M (+170.2%) vs. Q2 2025
- New holders
- 14
- 18 more added
- Sold out
- 7
- 10 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $2.54M |
| Q1 2026 | 56 | $8.12M |
| Q4 2025 | 55 | $8.84M |
| Q3 2025 | 58 | $81.8M |
| Q2 2025 | 51 | $30.3M |
| Q1 2025 | 48 | $39.0M |
| Q4 2024 | 54 | $44.9M |
| Q3 2024 | 47 | $45.3M |
| Q2 2024 | 43 | $56.3M |
| Q1 2024 | 42 | $90.8M |
| Q4 2023 | 46 | $90.0M |
| Q3 2023 | 34 | $15.7M |
| Q2 2023 | 33 | $1.82M |
| Q1 2023 | 83 | $4.79M |
| Q4 2022 | 86 | $4.15M |
| Q3 2022 | 93 | $9.13M |
| Q2 2022 | 112 | $122.1M |
| Q1 2022 | 116 | $167.8M |
| Q4 2021 | 106 | $269.2M |
| Q3 2021 | 105 | $360.2M |
| Q2 2021 | 101 | $389.0M |
| Q1 2021 | 74 | $225.2M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Vistagen Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 1 | $4 | 0.00% | 00.0% | Unchanged |
| Fairman Group, LLC | 29 | $103 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 56 | $199 | 0.00% | −422−88.3% | Reduced |
| Jones Financial Companies LLLP | 114 | $402 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 290 | $1.03K | 0.00% | +2+0.7% | Added |
| MAI Capital Management | 526 | $1.87K | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 582 | $2.00K | 0.00% | 00.0% | Unchanged |
| Performa Ltd (US), LLC | 1,000 | $3.55K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 3,453 | $12.3K | 0.00% | −86−2.4% | Reduced |
| Advisor Group Holdings, Inc. | 4,093 | $14.5K | 0.00% | −400−8.9% | Reduced |
| FNY Investment Advisers, LLC | 6,000 | $21.0K | 0.01% | +6,000 | New |
| Truvestments Capital LLC | 8,655 | $30.7K | 0.01% | +1,500+21.0% | Added |
| Schonfeld Strategic Advisors LLC | 10,883 | $38.6K | 0.00% | +10,883 | New |
| Blair William & Co | 12,573 | $44.6K | 0.00% | −73,293−85.4% | Reduced |
| Quadrature Capital Ltd | 15,752 | $55.8K | 0.00% | +15,752 | New |
| Kestra Advisory Services, LLC | 20,033 | $71.1K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 20,676 | $73.4K | 0.00% | +20,676 | New |
| HighTower Advisors, LLC | 20,828 | $73.9K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 23,302 | $82.7K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 25,667 | $91.1K | 0.00% | +2,854+12.5% | Added |
| Morgan Stanley | 27,534 | $97.7K | 0.00% | +15,387+126.7% | Added |
| Group One Trading, L.P. | 28,928 | $102.7K | 0.00% | +21,786+305.0% | Added |
| Gsa Capital Partners LLP | 31,486 | $112.0K | 0.01% | +31,486 | New |
| Bank of America Corp | 34,657 | $123.0K | 0.00% | +31,279+926.0% | Added |
| American Century Companies Inc | 41,072 | $145.8K | 0.00% | +10,009+32.2% | Added |
| Occudo Quantitative Strategies LP | 42,704 | $151.6K | 0.02% | +42,704 | New |
| Cubist Systematic Strategies, LLC | 43,953 | $156.0K | 0.00% | +43,953 | New |
| Northern Trust Corp | 48,093 | $170.7K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 60,152 | $213.5K | 0.00% | +60,152 | New |
| Walleye Capital LLC | 67,770 | $240.6K | 0.00% | +67,770 | New |
| Dimensional Fund Advisors LP | 68,017 | $241.4K | 0.00% | +24,655+56.9% | Added |
| XTX Topco Ltd | 69,712 | $247.5K | 0.01% | +69,712 | New |
| Persistent Asset Partners Ltd | 75,319 | $267.4K | 0.19% | −11,500−13.2% | Reduced |
| Susquehanna International Group, LLP | 85,594 | $303.9K | 0.00% | −29,774−25.8% | Reduced |
| State Street Corp | 96,858 | $343.8K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 113,062 | $401.4K | 0.04% | −307,703−73.1% | Reduced |
| Citadel Advisors LLC | 122,062 | $433.3K | 0.00% | +122,062 | New |
| BML Capital Management, LLC | 150,000 | $532.5K | 0.49% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 157,032 | $557.5K | 0.00% | +131,200+507.9% | Added |
| Boothbay Fund Management, LLC | 197,024 | $699.4K | 0.02% | +19,166+10.8% | Added |
| AdvisorShares Investments LLC | 206,998 | $734.8K | 0.12% | +3,884+1.9% | Added |
| Almitas Capital LLC | 261,399 | $928.0K | 0.21% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 271,825 | $965.0K | 0.00% | −477,037−63.7% | Reduced |
| Two Sigma Investments, LP | 289,409 | $1.03M | 0.00% | +199,958+223.5% | Added |
| Geode Capital Management, LLC | 298,280 | $1.06M | 0.00% | +25,373+9.3% | Added |
| Jane Street Group, LLC | 302,683 | $1.07M | 0.00% | +207,632+218.4% | Added |
| Diadema Partners LP | 349,789 | $1.24M | 0.86% | −54,133−13.4% | Reduced |
| Renaissance Technologies LLC | 422,012 | $1.50M | 0.00% | +381,512+942.0% | Added |
| BlackRock, Inc. | 423,128 | $1.50M | 0.00% | +6,239+1.5% | Added |
| Soleus Capital Management, L.P. | 550,000 | $1.95M | 0.10% | +550,000 | New |
| Ikarian Capital, LLC | 620,869 | $2.20M | 0.50% | +19,166+3.2% | Added |
| Commodore Capital LP | 1,575,000 | $5.59M | 0.27% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,687,735 | $5.99M | 0.00% | −71,907−4.1% | Reduced |
| Nantahala Capital Management, LLC | 1,978,492 | $7.02M | 0.43% | 00.0% | Unchanged |
| StemPoint Capital LP | 2,488,685 | $7.75M | 1.56% | +75,431+3.1% | Added |
| TCG Crossover Management, LLC | 2,676,580 | $9.50M | 0.47% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,060,000 | $10.9M | 0.26% | +3,060,000 | New |
| Janus Henderson Group PLC | 4,165,767 | $14.7M | 0.01% | +4,165,767 | New |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −447,939−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −34,638−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −22,946−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −22,536−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −7,721−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −6,410−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −3,297−100.0% | Sold out |